Probiotics in paediatric gastrointestinal diseases

Journal of Paediatrics and Child Health

Volumn 43, Issue 5, 2007, Pages 331-336

  Lemberg, Daniel A ^a,b   Ooi, Chee Yee ^a,b   Day, Andrew S ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SYDNEY CHILDREN'S HOSPITAL   (Australia)

Author keywords

Antibiotic; Children; Diarrhoea; Probiotic

Indexed keywords

ANTIBIOTIC AGENT; METRONIDAZOLE; PLACEBO; PROBIOTIC AGENT;

BACTEREMIA; CLINICAL TRIAL; DIARRHEA; DRUG SAFETY; DRUG TOLERABILITY; ELECTROLYTE DISTURBANCE; ENTERITIS; GASTROINTESTINAL DISEASE; HEALTH SERVICE; HUMAN; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS GASSERI; LACTOBACILLUS REUTERI; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW; SACCHAROMYCES BOULARDII;

CHILD; CHILD, PRESCHOOL; GASTROINTESTINAL DISEASES; HUMANS; INFANT; PROBIOTICS;

EID: 34247855723     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2007.01076.x     Document Type: Review

References (56)

1. Markowitz JE, Bengmark S. Probiotics in health and disease in the pediatric patient. Pediatr. Clin. North Am. 2002 49 : 127 41.
2. Lewis SJ, Freedman AR. Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease. Aliment. Pharmacol. Ther. 1998 12 : 807 22.
3. Mack DR, Ahrne S, Hyde L, Wei S, Hollingsworth MA. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 2003 52 : 827 33.
4. Surawicz CM. Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans. Best Pract. Res. Clin. Gastroenterol. 2003 17 : 775 83.
5. Qamar A, Aboudola A, Warny M et al. Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice. Infect. Immun. 2001 69 : 2762 5.
6. Castagliuolo I, Riegler MF, Valenick L et al. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect. Immun. 1999 67 : 302 7.
7. Pothoulakis C, Kelly CP, Joshi MA et al. Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology 1993 104 : 1108 15.
8. Tasteyre A, Barc MC, Karjalainen T et al. Inhibition of in vitro cell adherence of Clostridium difficile by Saccharomyces boulardii. Microb. Pathog. 2002 32 : 219 25.
9. Day AS. Use of complementary and alternative therapies by children attending gastroenterology outpatient clinics. J. Paediatr. Child Health 2002 38 : 343 6.
10. Day AS, Whitten KE, Bohane TD. Use of complementary and alternative medicines by children and adolescents with Inflammatory Bowel Disease. J. Paediatr. Child Health 2004 40 : 681 4.
11. MacLennan AH, Wilson DH, Taylor AW. Prevalence and cost of alternative medicine in Australia. Lancet 1996 347 : 569 73.
12. Sawyer MG, Gannoni AF, Toogood IR, Antoniou G, Rice M. The use of alternative therapies by children with cancer. Med. J. Aust. 1994 160 : 320 2.
13. Van Niel CW, Feudtner C, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002 109 : 678 84.
14. Kurugol Z, Koturoglu G. Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Paediatr. 2005 94 : 44 7.
15. Kotowska M, Albrecht P, Szajewska H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment. Pharmacol. Ther. 2005 21 : 583 90.
16. Arvola T, Laiho K, Torkkeli S et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhoea in children with respiratory infections: a randomised study. Pediatrics 1999 104 : e64.
17. Vanderhoof JA, Whitney DB, Antonson DL et al. Lactobacillus GG in the prevention of antibiotic associated diarrhoea in children. J. Pediatr. 1999 135 : 564 7.
18. Surawicz CM, McFarland LV, Greenberg RN et al. The search for a better treatment for recurrent Clostridium difficile disease; use of high-dose vancomycin combined with Saccharomyces boulardii. Clin. Infect. Dis. 2000 31 : 1012 17.
19. Gionchetti P, Rizzello F, Helwig U et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003 124 : 1202 9.
20. Gionchetti P, Rizzello F, Venturi A et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000 119 : 305 9.
21. Avendano P, Matson DO, Long J et al. Costs associated with office visits for diarrhea in infants and toddlers. Pediatr. Infect. Dis. J. 1993 12 : 897 902.
22. Matson DO, Estes MK. Impact of rotavirus infection at a large pediatric hospital. J. Infect. Dis. 1990 162 : 598 604.
23. Glass RI, Lew JF, Gangarosa RE, LeBaron CW, Ho MS. Estimates of morbidity and mortality rates for diarrheal diseases in American children. J. Pediatr. 1991 118 : S27 33.
24. Cicirello HG, Glass RI. Current concepts of the epidemiology of diarrheal diseases. Semin. Pediatr. Infect. Dis. 1994 5 : 163 7.
25. Djuretic T, Ramsay M, Gay N et al. An estimate of the proportion of diarrhoeal disease episodes seen by general practitioners attributable to rotavirus in children under 5 y of age in England and Wales. Acta Paediatr. Suppl. 1999 88 : 38 41.
26. Armon K, Stephenson T, Gabriel V et al. Determining the common medical presenting problems to an accident and emergency department. Arch. Dis. Child. 2001 84 : 390 2.
27. Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J. Pediatr. Gastroenterol. Nutr. 2001 33 (Suppl. 2 S17 25.
28. Huang JS, Bousvaros A, Lee JW et al. Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig. Dis. Sci. 2002 47 : 2625 34.
29. Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for treating acute infectious diarrhea. Cochrane Database Syst. Rev. 2003 4 : CD003048.pub 2.
30. Szymanski H, Pejcz J, Jawein M et al. Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactobacillus rhamnosus strains - a randomized, double-blind, placebo-controlled trial. Aliment. Pharmacol. Ther. 2006 23 : 247 53.
31. Bergogne-Berezin E. Treatment and prevention of antibiotic-associated diarrhoea. Int. J. Antimicrob. Agents 2000 16 : 521 6.
32. McFarland LV. Epidemiology, risk factors and treatments for antibiotic-associated diarrhoea. Dig. Dis. 1998 16 : 292 307.
33. Barbut F, Meynard JL. Managing antibiotic associated diarrhoea. BMJ 2002 324 : 1345 6.
34. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic-associated diarrhoea: meta-analysis. BMJ 2002 324 : 1361 6.
35. Cremonini F, DiCaro S, Nista EC et al. Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment. Pharmacol. Ther. 2002 16 : 1461 7.
36. Szajewska H, Mrukowicz J. Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment. Pharmacol. Ther. 2005 22 : 365 72.
37. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic diarrhea and treatment of Clostridium difficile disease. Am. J. Gastroenterol. 2006 101 : 812 22.
38. Seki H, Shiohara M, Matsumura T et al. Prevention of antibiotic- associated diarrhoea in children by Clostridium butyricum MIYAIRI. Pediatr. Int. 2003 45 : 86 90.
39. Kimmey MB, Elmer GW, Surawicz CM. Prevention of further relapses of Clostridium difficile colitis with Saccharomyces boulardii. Dig. Dis. Sci. 1990 35 : 897 901.
40. Buts JP, Corthier G, Delmee M. Saccharomyces boulardii for Clostridium difficile-associated enteropathies in infants. J. Pediatr. Gastroenterol. Nutr. 1993 16 : 419 25.
41. Wullt M, Haqslatt ML, Odenholt I. Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial. Scand. J. Infect. Dis. 2003 35 : 365 7.
42. Kruis W, Fric P, Lukas M et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004 53 : 1617 23.
43. Fedorak RN, Madsen KL. Probiotics and the management of inflammatory bowel disease. Inflamm. Bowel Dis. 2004 10 : 286 99.
44. Gupta P, Andrew H, Kirschner BS, Guandalini S. Is Lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J. Pediatr. Gastroenterol. Nutr. 2000 31 : 453 7.
45. Bousvaros A, Guandalini S, Baldassano RN et al. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm. Bowel Dis. 2005 11 : 833 9.
46. Oksanen PJ, Salminen S, Saxelin M et al. Prevention of travellers' diarrhoea by Lactobacillus GG. Ann. Med. 1990 22 : 53 6.
47. Bin-Nun A, Bromiker R, Wilschanski M et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J. Pediatr. 2005 147 : 192 6.
48. Lin HC, Su BH, Chen AC et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005 115 : 1 4.
49. Land MH, Rouster-Stevens K, Woods CR et al. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005 115 : 178 81.
50. O'Sullivan MA, O'Morain CA. Bacterial supplementation in the irritable bowel syndrome: a randomised double-blind placebo-controlled crossover study. Dig. Liver Dis. 2000 32 : 294 301.
51. Kim HJ, Camilleri M, McKinzie S et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther. 2003 17 : 895 904.
52. Salminen MK, Rautelin H, Tynkkynen S et al. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin. Infect. Dis. 2004 38 : 62 9.
53. Day AS, Abbott GD. D-lactic acidosis in short bowel syndrome. N. Z. Med. J. 1999 112 : 277 8.
54. Dani C, Biadaioli R, Bertini G et al. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. Biol. Neonate 2002 82 : 103 8.
55. Zhang L, Li N, Neu J. Probiotics for preterm infants. Neo. Rev. 2005 6 : e227 32.
56. Schanler RJ. Probiotics and necrotising enterocolitis in premature infants. Arch. Dis. Child. Fetal Neonatal Ed. 2006 91 : F395 7.